Myriad Genetics Inc (LTS:0K3W)
$ 13.635 0.293 (2.19%) Market Cap: 1.24 Bil Enterprise Value: 1.29 Bil PE Ratio: 0 PB Ratio: 1.70 GF Score: 63/100

Q1 2023 Myriad Genetics Inc Earnings Call Transcript

May 03, 2023 / 08:30PM GMT
Release Date Price: $21.63 (+1.11%)
Matthew Scalo
Myriad Genetics, Inc. - SVP of IR

Okay. Good afternoon, and welcome to the Myriad Genetics First Quarter 2023 Earnings Call. During the call, we will review the financial results we released today, and afterwards, we will host a question-and-answer session.

Our quarterly earnings release was issued this afternoon on Form 8-K and can be found on our website at investor.myriad.com.

I'm Matt Scalo, Senior Vice President of Investor Relations. And on the call with me today are Paul Diaz, our President and Chief Executive Officer; Bryan Riggsbee, our Chief Financial Officer; Nicole Lambert, our Chief Operating Officer; and Mark Verratti, our Chief Commercial Officer.

This call can be heard live via webcast at investor.myriad.com, and a recording will be archived in the Investors section of our website along with this slide presentation.

Please note that some of the information presented today contains projections or other forward-looking statements regarding future events or the future financial performance of the company. These statements are based on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot